I Multidisciplinar Open Classroom in Viral and Bacterial Infections of the Liver.
• Sponsored by Gilead Sciences Laboratory, the reunion is accredited by the Menendez Pelayo International University and sponsored by the Spanish Association for the Study of the Liver.
• One hundred hepatologists Spaniards have gathered in this first Open Classroom Cross is drawn into a discussion forum on infectious diseases of the liver.
• The ideal drug is one that achieves a potent viral suppression (effectiveness) as long as possible (no resistance).
• Around 400 million people worldwide are infected with Hepatitis B, and 200 million for hepatitis C. Most do not know.
• In Spain there are between 300,000 and 400,000 people with hepatitis B, and between 800,000 and one million with hepatitis C.
El Palacio de la Magdalena Santander I just host the Open Classroom in Cross Viral and Bacterial Infections of the liver that has brought over one hundred nationally hepatologists.
The objective of this class has been updated knowledge related to bacterial and viral infectious diseases of the liver, especially hepatitis B and C, so that specialists may be transferred to everyday clinical practice, it has been established what should be the action protocols in many cases. It also has a special focus on the most controversial points of the treatment of these diseases. This classroom has led Dr. Fernando Pons Romero, Professor of Medicine and Chief of Digestive Medicine of the Hospital Universitario Marqués de Valdecilla, Dr. José Luis Calleja, Deputy Medical Service of Gastroenterology Hospital Universitario Puerta de Hierro, and Dr. Javier Garcia Crespo, Physician Assistant Digestive Medicine Department of Hospital Universitario Marqués de Valdecilla. Sponsored by Gilead Sciences Laboratory, the reunion had the accreditation of the Menéndez Pelayo International University and sponsored by the Spanish Association for the Study of the Liver.
This meeting, held for the first time in Spain, intends to become a forum for discussion of liver disease in the coming years. It has highlighted the importance of multidisciplinary treatment of viral and bacterial diseases of the liver, focusing on the need to work together in addressing them to ensure that treatment is successful.
Thus, Dr. Fernando Pons explains that for this first class multidisciplinary "have been selected infectious diseases for several reasons, firstly by its frequency, because of its high morbidity and have at present a very effective therapeutic arsenal can control. " We therefore have analyzed the liver related to hepatitis B and C which are responsible for a significant number of hepatitis, which if not treated properly can lead to the development of liver cirrhosis and even liver cancer.
Similarly, we have studied the bacterial diseases that can present and cirrhotic patients whose diagnosis and treatment is essential because they are a very important cause of mortality.
Here I Cross Open Classroom in viral and bacterial diseases of the liver has been spoken of spontaneous bacterial peritonitis, bacterial infections in cirrhotic patients in hepatic disease or infectious diseases. About C virus has affected the clinical extrahepatic manifestations of this virus in the predictors of non-modifiable and modifiable treatment response and treatment of hepatitis C after liver transplantation. As for the B virus, in this meeting have been presented the epidemiological changes of infection by this virus in Spain, explaining the diagnosis of infection and evolving forms of B virus infection highlighting the therapeutic options currently available.
Specialist Hospital Universitario Marqués de Valdecilla stresses the importance of these meetings as a forum for exchange of knowledge between hepatologists and other specialists who treat diseases that are related to these infections and to alter its natural history, hence the importance the multidisciplinary approach. "
Hepatitis B and C. Treatment
Among other points, in this classroom were addressed novel aspects in epidemiology, natural history, diagnosis and treatment of chronic infection by hepatitis B. Dr. José Luis Calleja, Deputy Medical Service of Gastroenterology Hospital Universitario Puerta de Hierro, emphasizes that the majority of treatments are prescribed for long term is essential to choose appropriate candidates for the treatment. At present, most of the international consensus to recommend treating only those patients who present with histologic and analytical data relevant to active disease. " In this sense, it emphasized the importance of team-resistant effectiveness when planning appropriate treatment. The ideal drug is one that achieves a potent viral suppression (effectiveness) as long as possible (no resistance). In this sense, the new generation of antiviral drugs such as tenofovir, a major breakthrough for the treatment of these patients and are regarded as drugs of choice, "clarifies Dr. Calleja.
Regarding hepatitis C, this reunion was discussed the possibility of improving the antiviral response by modifying factors: treatment of docility, the host and virus. It also emphasized the individualization of treatment, ie the adaptation of treatment to each patient and each type of virus to achieve optimal viral response in the shortest possible time and with fewer side effects. Thus, Dr. Javier Crespo, Associate Medical Digestive Medicine Department of Hospital Universitario Marqués de Valdecilla, explains that "it is important impact on reducing the treatment time in patients infected with genotype I with low viral load and that they possible treatment of 6 months instead of 12 without loss of efficiency. " On the other hand, in the Open Classroom I Cross in viral and bacterial diseases of the liver, is said to increase the treatment in some cases of infection with genotype 3 and high viral loads do not exhibit an early virological response.
Hepatitis B and C. Prevalence
One in 12 people worldwide are living with hepatitis B or C, and most have known the disease. According to estimates by the World Health Organization estimated that there are approximately 400 million people globally affected by hepatitis B and between 170 and 200 million cases of hepatitis C. One in three people worldwide have ever been exposed to hepatitis B or C.
The prevalence of these diseases is highest in China, Southeast Asia and tropical Africa, and in turn the lowest in North America, Western Europe and Australia.
5% of the world population are carriers of hepatitis B virus and produces two million deaths annually caused by this virus. In Southeast Asia and in sub-Saharan Africa 10% of the population are chronic carriers. The level of prevalence of hepatitis B is such that the number of infected is 10 times higher than those infected with the AIDS virus and its transmission is 100 times easier than that of HIV.
In Spain, there are 12,000 cases of hepatitis B each year. Between 5 and 10% become chronic hepatitis B and approximately 250 cases developed hepatocarcinoma (liver cancer). In total, there are between 300,000 and 400,000 Spaniards infected by this virus, approximately 1% of the population. For its part, the prevalence of hepatitis C infection is relatively high, with between 800,000 and one million infected people in our country. It is estimated that nearly a million Spaniards are unaware that they carry some hepatitis viruses.
Complications commonly associated with hepatitis B and C are cirrhosis, liver failure and liver cancer, disorders that may affect 20 percent of these patients. The existence of such factors as alcohol consumption, being male, having been infected in late age and being infected by human immunodeficiency virus negative impact on prognosis and disease progression.
About Gilead Sciences
Gilead Sciences, sponsor of the Open Classroom I Cross in viral and bacterial infections of the liver, is a biopharmaceutical company that discovers, develops and markets innovative treatments in areas with unresolved medical needs. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead Sciences now sells Viread ® (tenofovir), a single administration of antiviral daily for the treatment of chronic hepatitis B and Hepsera ®, widely used in Europe. In addition, the company is developing small molecule compounds for the treatment of hepatitis C and a hepatoprotective liver fibrosis due to hepatitis.
Sunday, February 15, 2009
Pill and wife celebrate 30 years to grow together.
• Yesterday was inaugurated in Madrid the exhibition "Pill and women 30 years of evolution" that will tour major cities in Spain.
• According to experts, the pill has undergone in recent years a radical transformation and now have fewer side effects and many health benefits.
Yesterday, October 7, 2008 was held in Spain on 30th anniversary of the decriminalization of the contraceptive pill. A date which marked a milestone in the history of women and society of our country, and that somehow symbolized the arrival of a new era of openness and freedom.
Since then, many things have changed for women and society itself, but so has the pill. Now, three decades later, the pill is no longer used only as a contraceptive method, but developments in recent years have focused on meeting additional health needs and welfare of women.
This has been reflected in the "Pill and women: 30 years of evolution" which was presented yesterday at the hands of the Spanish Society of Gynecology and Obstetrics, the Spanish Society of Contraception and in collaboration with Bayer Schering Pharma. The sample includes the testimonies of 30 women on the pill and its evolution over these 30 years.
According to sociologist Jose M Bleda, "it is striking to see how women have changed in so little time. Its more professional, its growing integration into working life and other facets of development has marked his career in 30 years and has led him to be more demanding and have greater concern for their health, wellbeing and physical appearance .
In these years there has been a substantial change in relation to the pill. Once the efficacy and safety of contraceptives, recent developments have been designed to meet the changing needs of health and welfare of women. In this sense, as the widow of Dr. Esther, Chairman of the SEC and Gynecologist Hospital of Guadalajara, "Reducing the dose of hormone and the incorporation of new progestins increasingly similar to natural progesterone in women has been key to achieving other benefits to health and welfare of women. " Now, the contraceptive pill also has a therapeutic use to reduce symptoms associated with menstruation such as menorrhagia (abundant bleeding) or dysmenorrhea (menstrual pain), treatment of acne and seborrhea, or alleviation of symptoms associated andalusia Premenstrual syndrome. Sometimes, these signs have become characteristic of oral contraception or treatment specialists recommend that outside purely contraceptive. This means that over 1,700,000 women choose this method in Spain.
Along with all of them in this presentation has been Mr. Theo van der Loo, Managing Director of Bayer Healthcare in Spain, which now incorporates the company that once was responsible for the introduction of the pill in our country, and which now represents 30 years after the breakthrough and development in this method since, and wanted to support with their presence Sponsored by: In collaboration with: the initiative and show the company's commitment to continue working on improving the health and quality of life of women.
On exposure
The exhibition is based on the personal testimony of 30 Spanish women, of varying age and condition, we have personal experience with the contraceptive pill. Among them we find housewives, students, journalists or gynecologists.
Some of the familiar faces that have given their testimony are actresses Monica Estarreado, or Powdery Ana Carla Hidalgo. The show also has collected the testimony of political or professional recognition by the President of the Spanish Federation of Women Entrepreneurs, Business & Professional (FEMENP), Carmen Sanz Chacon or writer Mariana Jara.
Also the exhibition runs through the development of oral contraception in the last 30 years, so informative and entertaining.
Pill and Women: 30 years of evolution starts today in Madrid, but your first stop for the general public will be in Santiago de Compostela from October 28 to November 1. Other cities that will traverse Bilbao, Sevilla, Valencia and Barcelona. In February revert back to Madrid where he will be a week before its closure. During his trip, the exhibition provides informative host various activities around the oral contraceptive. For the itinerary or further information: http://www.pildoraymujer.com.
30 years of decriminalization
On October 7, 1978 the courts gave the green light by the Law 45/1978 which approved the decriminalization of the use of the contraceptive pill. Today, 30 years later, the Spanish Association of Gynecology and Obstetrics (SEGO) and the Society of Contraception Esañola (SEC), supported by Bayer Shering Pharma, the company which marketed the first pill in our country, and we have held in Madrid with the opening of an exhibition that will tour the Spanish in the coming months.
Although oral contraceptives were being recent past as menstrual regulation, legalization of contraceptive use as the beginning of a new era for millions of Spanish, since that time, had the opportunity to choose when and how to conceive.
• According to experts, the pill has undergone in recent years a radical transformation and now have fewer side effects and many health benefits.
Yesterday, October 7, 2008 was held in Spain on 30th anniversary of the decriminalization of the contraceptive pill. A date which marked a milestone in the history of women and society of our country, and that somehow symbolized the arrival of a new era of openness and freedom.
Since then, many things have changed for women and society itself, but so has the pill. Now, three decades later, the pill is no longer used only as a contraceptive method, but developments in recent years have focused on meeting additional health needs and welfare of women.
This has been reflected in the "Pill and women: 30 years of evolution" which was presented yesterday at the hands of the Spanish Society of Gynecology and Obstetrics, the Spanish Society of Contraception and in collaboration with Bayer Schering Pharma. The sample includes the testimonies of 30 women on the pill and its evolution over these 30 years.
According to sociologist Jose M Bleda, "it is striking to see how women have changed in so little time. Its more professional, its growing integration into working life and other facets of development has marked his career in 30 years and has led him to be more demanding and have greater concern for their health, wellbeing and physical appearance .
In these years there has been a substantial change in relation to the pill. Once the efficacy and safety of contraceptives, recent developments have been designed to meet the changing needs of health and welfare of women. In this sense, as the widow of Dr. Esther, Chairman of the SEC and Gynecologist Hospital of Guadalajara, "Reducing the dose of hormone and the incorporation of new progestins increasingly similar to natural progesterone in women has been key to achieving other benefits to health and welfare of women. " Now, the contraceptive pill also has a therapeutic use to reduce symptoms associated with menstruation such as menorrhagia (abundant bleeding) or dysmenorrhea (menstrual pain), treatment of acne and seborrhea, or alleviation of symptoms associated andalusia Premenstrual syndrome. Sometimes, these signs have become characteristic of oral contraception or treatment specialists recommend that outside purely contraceptive. This means that over 1,700,000 women choose this method in Spain.
Along with all of them in this presentation has been Mr. Theo van der Loo, Managing Director of Bayer Healthcare in Spain, which now incorporates the company that once was responsible for the introduction of the pill in our country, and which now represents 30 years after the breakthrough and development in this method since, and wanted to support with their presence Sponsored by: In collaboration with: the initiative and show the company's commitment to continue working on improving the health and quality of life of women.
On exposure
The exhibition is based on the personal testimony of 30 Spanish women, of varying age and condition, we have personal experience with the contraceptive pill. Among them we find housewives, students, journalists or gynecologists.
Some of the familiar faces that have given their testimony are actresses Monica Estarreado, or Powdery Ana Carla Hidalgo. The show also has collected the testimony of political or professional recognition by the President of the Spanish Federation of Women Entrepreneurs, Business & Professional (FEMENP), Carmen Sanz Chacon or writer Mariana Jara.
Also the exhibition runs through the development of oral contraception in the last 30 years, so informative and entertaining.
Pill and Women: 30 years of evolution starts today in Madrid, but your first stop for the general public will be in Santiago de Compostela from October 28 to November 1. Other cities that will traverse Bilbao, Sevilla, Valencia and Barcelona. In February revert back to Madrid where he will be a week before its closure. During his trip, the exhibition provides informative host various activities around the oral contraceptive. For the itinerary or further information: http://www.pildoraymujer.com.
30 years of decriminalization
On October 7, 1978 the courts gave the green light by the Law 45/1978 which approved the decriminalization of the use of the contraceptive pill. Today, 30 years later, the Spanish Association of Gynecology and Obstetrics (SEGO) and the Society of Contraception Esañola (SEC), supported by Bayer Shering Pharma, the company which marketed the first pill in our country, and we have held in Madrid with the opening of an exhibition that will tour the Spanish in the coming months.
Although oral contraceptives were being recent past as menstrual regulation, legalization of contraceptive use as the beginning of a new era for millions of Spanish, since that time, had the opportunity to choose when and how to conceive.
The stigma of mental illness results in a lack of resources.
• On Friday, October 10 is World Day of Mental Health.
• The prevalence of psychiatric disorders in Spain is high at around 20-25% of the population.
• The health care effort, both as a means of adequately trained personnel, which is below it as a "pro" to load.
• For every 100,000 inhabitants, in Spain there are 5.5 psychiatrists, while in another EU country there are 15 professionals.
• The rate of suicide mortality adjusted for age and sex of persons suffering from a schizophrenic disorder, is 9 times that of the general population.
• An important factor that affects the use of mental health services is the stigma and discrimination associated.
In Spain, about half a million people suffer from some form of serious mental disorder, however, mental illness is still not well known socially. The prevalence of psychiatric disorders in Spain is high at around 20-25% of the population.
At present there is widespread concern among patients, families and professionals regarding the need to ensure access to quality care to reduce the heavy burden of suffering and disability associated with mental disorders, therefore, the Spanish Foundation Psychiatric and Mental Health (FEPSM) joins the voices on the occasion of World Day of Mental Health, calling for a sustained and coherent effort to achieve that goal.
Mental disorders as a whole, in Europe are responsible for the greatest burden of disease pathology groups, ahead of cardiovascular disease or cancer. However, the effort of care, both as a means of adequately trained personnel, which is below it as a "pro" to load.
The reasons for this situation which is repeated in many countries, are manifold, ranging from stigma / discrimination associated with this group of disorders until the late introduction of psychiatric care to National Health System as has happened in our country, through suffering cuts on social protection in times of economic crisis.
There is a big difference between the number of professionals for the Mental Health in Spain and one of the most advanced countries of the European Union. Per 100,000 inhabitants, in Spain there are 5.5 psychiatrists, while in another EU country there are 15 professionals. If we attend to the number of nurses, found that in our country there are about 6 compared to 50 other European countries. On the other hand, if we refer to the number of occupational therapists, we find that in Spain with 0.5 per 100,000 population compared to 20 other countries. And finally, if we stop at the number of social workers, we see that while the figures in any of European countries is around 10 in our country we are close to 1.3. (Fuente. - Studio 2001 J. Luis Váquez, a professor at the University of Cantabria)
Interesting Facts
According to the Mental Health Strategy, Ministry of Health and Consumption, 2006, produced in collaboration with andalusia FEPSM, the prevalence of psychiatric disorders is high, 20-25% of the general population as the most rigorously designed epidemiological studies . In Spain it is estimated that half a million people suffer from some form of serious mental disorder. The distribution of prevalence by regional governments is relatively uniform, varying according to the present data between Andalusia and Catalonia 15.71 with 23.68.
Mental disorders are the cause of 10.5% of days lost for temporary disability and about 6.8% of the years of life lost due to permanent disability. The suicide mortality rate adjusted for age and sex of persons suffering from a schizophrenic disorder, is 9 times that of the general population. In major depression, the suicide risk is multiplied by 21, on eating disorders by 33 and 86 for drug addiction.
Spanish Foundation of Psychiatry and Mental Health (FEPSM)
One of the most important in recent years in the health world, has been the growth of mental illness. So all national health systems considered as a mental health emergency needs. In the immediate future, these problems will require greater attention in the planning and provision of social services and health.
In Spain, about half a million people suffer from some form of serious mental disorder, however, mental illness is still not well known socially. In this sense, the Spanish Foundation of Psychiatry and Mental Health (FEPSM) aims to contribute to knowledge development and refinement of Psychiatry and Mental Health, as well as their related disciplines, through meetings, publications, scientific events, developing research and other scientific and cultural activity.
This Foundation was created as an initiative of the Spanish Society of Psychiatry (SEP) and Spanish Society of Biological Psychiatry (SEPB) to give the general public of an instrument of service to the scientific advancement of Psychiatry and Mental Health in Spain.
• The prevalence of psychiatric disorders in Spain is high at around 20-25% of the population.
• The health care effort, both as a means of adequately trained personnel, which is below it as a "pro" to load.
• For every 100,000 inhabitants, in Spain there are 5.5 psychiatrists, while in another EU country there are 15 professionals.
• The rate of suicide mortality adjusted for age and sex of persons suffering from a schizophrenic disorder, is 9 times that of the general population.
• An important factor that affects the use of mental health services is the stigma and discrimination associated.
In Spain, about half a million people suffer from some form of serious mental disorder, however, mental illness is still not well known socially. The prevalence of psychiatric disorders in Spain is high at around 20-25% of the population.
At present there is widespread concern among patients, families and professionals regarding the need to ensure access to quality care to reduce the heavy burden of suffering and disability associated with mental disorders, therefore, the Spanish Foundation Psychiatric and Mental Health (FEPSM) joins the voices on the occasion of World Day of Mental Health, calling for a sustained and coherent effort to achieve that goal.
Mental disorders as a whole, in Europe are responsible for the greatest burden of disease pathology groups, ahead of cardiovascular disease or cancer. However, the effort of care, both as a means of adequately trained personnel, which is below it as a "pro" to load.
The reasons for this situation which is repeated in many countries, are manifold, ranging from stigma / discrimination associated with this group of disorders until the late introduction of psychiatric care to National Health System as has happened in our country, through suffering cuts on social protection in times of economic crisis.
There is a big difference between the number of professionals for the Mental Health in Spain and one of the most advanced countries of the European Union. Per 100,000 inhabitants, in Spain there are 5.5 psychiatrists, while in another EU country there are 15 professionals. If we attend to the number of nurses, found that in our country there are about 6 compared to 50 other European countries. On the other hand, if we refer to the number of occupational therapists, we find that in Spain with 0.5 per 100,000 population compared to 20 other countries. And finally, if we stop at the number of social workers, we see that while the figures in any of European countries is around 10 in our country we are close to 1.3. (Fuente. - Studio 2001 J. Luis Váquez, a professor at the University of Cantabria)
Interesting Facts
According to the Mental Health Strategy, Ministry of Health and Consumption, 2006, produced in collaboration with andalusia FEPSM, the prevalence of psychiatric disorders is high, 20-25% of the general population as the most rigorously designed epidemiological studies . In Spain it is estimated that half a million people suffer from some form of serious mental disorder. The distribution of prevalence by regional governments is relatively uniform, varying according to the present data between Andalusia and Catalonia 15.71 with 23.68.
Mental disorders are the cause of 10.5% of days lost for temporary disability and about 6.8% of the years of life lost due to permanent disability. The suicide mortality rate adjusted for age and sex of persons suffering from a schizophrenic disorder, is 9 times that of the general population. In major depression, the suicide risk is multiplied by 21, on eating disorders by 33 and 86 for drug addiction.
Spanish Foundation of Psychiatry and Mental Health (FEPSM)
One of the most important in recent years in the health world, has been the growth of mental illness. So all national health systems considered as a mental health emergency needs. In the immediate future, these problems will require greater attention in the planning and provision of social services and health.
In Spain, about half a million people suffer from some form of serious mental disorder, however, mental illness is still not well known socially. In this sense, the Spanish Foundation of Psychiatry and Mental Health (FEPSM) aims to contribute to knowledge development and refinement of Psychiatry and Mental Health, as well as their related disciplines, through meetings, publications, scientific events, developing research and other scientific and cultural activity.
This Foundation was created as an initiative of the Spanish Society of Psychiatry (SEP) and Spanish Society of Biological Psychiatry (SEPB) to give the general public of an instrument of service to the scientific advancement of Psychiatry and Mental Health in Spain.
Saturday, February 14, 2009
Conclusions of the XXIII Annual Meeting of the Spanish Group of Photobiology.
*
Are we protected from the sun an umbrella? What is therapeutic light?
*
More than 40 experts in dermatology, physics, chemistry, meteorology, biology and pharmacy, have presented this weekend in Barcelona the latest research that reveals the keys to these questions.
More than 40 recognized experts in the fields of dermatology, physics, chemistry, meteorology, biology and pharmacy, have participated in the XXIII Annual Meeting of the Spanish Group of Photobiology (GEF) held this weekend in Barcelona. During the meeting, there have been recent developments and research on the effects of sunlight and other sources of artificial light on health in general and in particular the skin, and its possible practical application in the prevention damage.
"Mindful of the effects of solar radiation on the immune system of humans, a large group of professionals decided to create this group and pool our efforts to prevent its negative consequences and exploit the positive towards the health of humans , "said Dr. José Manuel Carrascosa, coordinator of the GEF and dermatologist Service of Dermatology Hospital Universitari Germans Trias i Pujol" Can Ruti.
This year, in terms of diagnosis and treatment of diseases, mainly skin, experts presented the latest developments related to the treatment of skin cancer, psoriasis and vitiligo with phototherapy, fotoquimioterapia (PUVA) and photodynamic therapy.
This block has been reinforced by the launch of the first theoretical-practical course of phototherapy to dermatologists and dermatology residents, organized by the GEF and held at the Hospital de Sant Pau and Santa Creu of Barcelona, whose aim was to updating and deepening of the methodological aspects of some of the variants of phototherapy and studying the most common photosensitivity. The increasing number of patients with these diseases and the limited number of Photobiology and phototherapy limit access of many users of public health to these treatments. Both the course and in the reunion of the GEF, have prestigious dermatologists like Dr. José Manuel Carrascosa, coordinator of the GEF and dermatologist Service of Dermatology Hospital Universitari Germans Trias i Pujol "Can Ruti" Dr. Agustín Alomar, Chief of Dermatology of the Hospital de la Santa Creu i Sant Pau and Dr. Mario Lecha, dermatologist Dermatology Service, Hospital Clínic i Provincial and founding member of the GEF.
As for the latest research on the adverse effects of sunlight on human health include the presentation of the study by Joseph A. Martínez and M. Lozano Utrillas Pilar, professors in the Department of Thermodynamics, Faculty of Physics, University of Valencia, which shows that, far from much of the population believes the umbrella is not enough to protect us from the negative effects of the sun . The study concludes that the diffuse radiation under the umbrella is 35% which equates to an ICU for 3 or 4, so we can burn it too low. In case you are putting the risk is lower, but if you are sitting or standing under it must also add radiation by reflection from the sand (25%) or grass (33%).
Josep Montero, pharmaceutical ISDIN and founding member of the GEF, said that "these findings is essential to remind people that, despite that we will be under the umbrella on the beach, pool or field, it is very important to apply photoprotective one suited to the needs of each type of skin that protect us and help prevent skin cancer. "
About the GEF
The GEF is a multidisciplinary group, attached to the Spanish Academy of Dermatology and Venerology, born in 1988 to promote the exchange of scientific knowledge about the effects of radiation of light in the earth and man, studying the effects of artificial light sources and assess the risks from exposure to light sources.
Throughout his more than 20 years of work, the GEF has undertaken projects relating to the fields of Photobiology (science that studies the interaction between electromagnetic radiation and life), fotodiagnóstico, phototherapy and photoprotection, activity sun and the ozone layer. Moreover, it has worked on many skin diseases and drug reactions, batteries fotoparches, skin diseases and cancer, regulation of the tanning booth ....
Since its inception, ISDIN, leading dermatology pharmaceutical company in the Spanish market, has supported and publicized the work of the GEF, as well as holding its annual reunion in several Spanish cities.
http://www.aedv.es/grupos_trabajo/fotobiologia/
Are we protected from the sun an umbrella? What is therapeutic light?
*
More than 40 experts in dermatology, physics, chemistry, meteorology, biology and pharmacy, have presented this weekend in Barcelona the latest research that reveals the keys to these questions.
More than 40 recognized experts in the fields of dermatology, physics, chemistry, meteorology, biology and pharmacy, have participated in the XXIII Annual Meeting of the Spanish Group of Photobiology (GEF) held this weekend in Barcelona. During the meeting, there have been recent developments and research on the effects of sunlight and other sources of artificial light on health in general and in particular the skin, and its possible practical application in the prevention damage.
"Mindful of the effects of solar radiation on the immune system of humans, a large group of professionals decided to create this group and pool our efforts to prevent its negative consequences and exploit the positive towards the health of humans , "said Dr. José Manuel Carrascosa, coordinator of the GEF and dermatologist Service of Dermatology Hospital Universitari Germans Trias i Pujol" Can Ruti.
This year, in terms of diagnosis and treatment of diseases, mainly skin, experts presented the latest developments related to the treatment of skin cancer, psoriasis and vitiligo with phototherapy, fotoquimioterapia (PUVA) and photodynamic therapy.
This block has been reinforced by the launch of the first theoretical-practical course of phototherapy to dermatologists and dermatology residents, organized by the GEF and held at the Hospital de Sant Pau and Santa Creu of Barcelona, whose aim was to updating and deepening of the methodological aspects of some of the variants of phototherapy and studying the most common photosensitivity. The increasing number of patients with these diseases and the limited number of Photobiology and phototherapy limit access of many users of public health to these treatments. Both the course and in the reunion of the GEF, have prestigious dermatologists like Dr. José Manuel Carrascosa, coordinator of the GEF and dermatologist Service of Dermatology Hospital Universitari Germans Trias i Pujol "Can Ruti" Dr. Agustín Alomar, Chief of Dermatology of the Hospital de la Santa Creu i Sant Pau and Dr. Mario Lecha, dermatologist Dermatology Service, Hospital Clínic i Provincial and founding member of the GEF.
As for the latest research on the adverse effects of sunlight on human health include the presentation of the study by Joseph A. Martínez and M. Lozano Utrillas Pilar, professors in the Department of Thermodynamics, Faculty of Physics, University of Valencia, which shows that, far from much of the population believes the umbrella is not enough to protect us from the negative effects of the sun . The study concludes that the diffuse radiation under the umbrella is 35% which equates to an ICU for 3 or 4, so we can burn it too low. In case you are putting the risk is lower, but if you are sitting or standing under it must also add radiation by reflection from the sand (25%) or grass (33%).
Josep Montero, pharmaceutical ISDIN and founding member of the GEF, said that "these findings is essential to remind people that, despite that we will be under the umbrella on the beach, pool or field, it is very important to apply photoprotective one suited to the needs of each type of skin that protect us and help prevent skin cancer. "
About the GEF
The GEF is a multidisciplinary group, attached to the Spanish Academy of Dermatology and Venerology, born in 1988 to promote the exchange of scientific knowledge about the effects of radiation of light in the earth and man, studying the effects of artificial light sources and assess the risks from exposure to light sources.
Throughout his more than 20 years of work, the GEF has undertaken projects relating to the fields of Photobiology (science that studies the interaction between electromagnetic radiation and life), fotodiagnóstico, phototherapy and photoprotection, activity sun and the ozone layer. Moreover, it has worked on many skin diseases and drug reactions, batteries fotoparches, skin diseases and cancer, regulation of the tanning booth ....
Since its inception, ISDIN, leading dermatology pharmaceutical company in the Spanish market, has supported and publicized the work of the GEF, as well as holding its annual reunion in several Spanish cities.
http://www.aedv.es/grupos_trabajo/fotobiologia/
The Hepatitis B vaccination of health professionals is required to perform their work.
• About 95 percent of the health care of our environment is vaccinated against Hepatitis B.
• Failure of the immunization schedule for this group of legal and industrial implications
• Working in a sensitive habitat, the risk of occupational health is above average and the consequences of transmission of Hepatitis A and B are most relevant.
• The philosophy behind this concept is to protect oneself and others by vaccination.
• Ignorance of the working calendar of the immigrant population increases the risks of contagion and sobrevacunación.
• The scientific community is working on a protocol for action in the event of an influenza pandemic.
• The policy approach of Public Health means that, thanks to the immunization schedule for children, young people entering the labor market are better protected than the older population.
Health professionals should be vaccinated for the performance of their work. The rotundity of the sentence, the core of the conference organized by the Center for Immunization in the workplace (OVAL) today, Thursday, February 5, 2009, from 11:00 in the Company Bilbaina is based on a goals: minimizing the risk to others. As John says Goiri, president of the Academy of Medical Sciences of Bilbao and coordinator of the observatory, "Vaccination is a medical fitness test, especially as a means of preventing infection, both to themselves and colleagues to patients.
OVAL coordinator understands that "health professionals, and other labor groups at risk, must exercise extreme vigilance when it comes to health care. Not surprisingly, working in an environment where the risk is above average and the consequences of transmission of hepatitis B are more relevant. Andalusia handled in many cases, people with immune deficiencies are more serious sequelae.
The conference organized by the vaccinations OVAL seen as a test of capacity to work, both from a legal perspective and from the standpoint of occupational medicine. The judge of the administrative division of the Tribunal Superior de Justicia del País Vasco, Luis Garrido, explain what are the legal requirements for the performance of the health profession, with special emphasis on the criterion of medical and fitness of the worker to his job, along with preventive measures that work proceed in its case. " He recalled what the legal consequences are brought about by a breach of infection immunization schedule.
The president of the National Commission of Occupational Medicine, Mary Castilian, also recommended "an appropriate vaccination reduces rates of infection and the risk to others. Health professionals face a greater responsibility than other professionals and have to monitor this issue as a clear measure of job protection. " Both voices have been moderated by Dr. Juan José Díaz Franco.
It is, however, has already warned that a deep draft. Juan Goiri that "about 95 percent of the health care of our environment is vaccinated against Hepatitis B. The philosophy behind this concept is to protect oneself and others by vaccination. "To this we must add another fact that underscores the president of the Academy of Medical Sciences of Bilbao. "The policy approach of Public Health means that, thanks to the immunization schedule for children, young people entering the labor market are better protected than the older population."
Also, the time of updating the knowledge organized by the OVAL has reviewed the three most common types of vaccines in adults: influenza vaccine, tetanus vaccine and vaccines against hepatitis B. The head of vaccines and monitoring of management of Public Health of the Basque government, José María Arteagoitia has reviewed the current status of vaccine, and future prospects. This field is particularly important with the analysis of a virtual scene: how to act in the event of an influenza pandemic? The expert says that "has established a protocol on who to vaccinate first vaccination and what criteria should be followed."
In the field of tetanus vaccine, José Antonio Navarro-Alonso, a member of the European Commission on Prevention, revised criteria such as the risk of hipervacunación-economic carries a surcharge, the more discomfort and possible side-effects and lack of timing vaccine followed by the immigrant population. Following these reflections, Juan Goiri advocates the creation of a universal vaccination record, which reduces the margin of error. "
In any of the aforementioned types of vaccines, their administration is voluntary within the healthcare workplace. Unlike in the case of the vaccine for Hepatitis B. Luis Urbiztondo, section chief of infectious disease prevention for the general direction of Public Health of Catalonia, increased the possibility of reducing the number of doses required for a proper prophylaxis. Scientific research towards a vaccine for life ", a concept that, in the words of John Goiri," would significantly advance the health workforce of health professionals.
• Failure of the immunization schedule for this group of legal and industrial implications
• Working in a sensitive habitat, the risk of occupational health is above average and the consequences of transmission of Hepatitis A and B are most relevant.
• The philosophy behind this concept is to protect oneself and others by vaccination.
• Ignorance of the working calendar of the immigrant population increases the risks of contagion and sobrevacunación.
• The scientific community is working on a protocol for action in the event of an influenza pandemic.
• The policy approach of Public Health means that, thanks to the immunization schedule for children, young people entering the labor market are better protected than the older population.
Health professionals should be vaccinated for the performance of their work. The rotundity of the sentence, the core of the conference organized by the Center for Immunization in the workplace (OVAL) today, Thursday, February 5, 2009, from 11:00 in the Company Bilbaina is based on a goals: minimizing the risk to others. As John says Goiri, president of the Academy of Medical Sciences of Bilbao and coordinator of the observatory, "Vaccination is a medical fitness test, especially as a means of preventing infection, both to themselves and colleagues to patients.
OVAL coordinator understands that "health professionals, and other labor groups at risk, must exercise extreme vigilance when it comes to health care. Not surprisingly, working in an environment where the risk is above average and the consequences of transmission of hepatitis B are more relevant. Andalusia handled in many cases, people with immune deficiencies are more serious sequelae.
The conference organized by the vaccinations OVAL seen as a test of capacity to work, both from a legal perspective and from the standpoint of occupational medicine. The judge of the administrative division of the Tribunal Superior de Justicia del País Vasco, Luis Garrido, explain what are the legal requirements for the performance of the health profession, with special emphasis on the criterion of medical and fitness of the worker to his job, along with preventive measures that work proceed in its case. " He recalled what the legal consequences are brought about by a breach of infection immunization schedule.
The president of the National Commission of Occupational Medicine, Mary Castilian, also recommended "an appropriate vaccination reduces rates of infection and the risk to others. Health professionals face a greater responsibility than other professionals and have to monitor this issue as a clear measure of job protection. " Both voices have been moderated by Dr. Juan José Díaz Franco.
It is, however, has already warned that a deep draft. Juan Goiri that "about 95 percent of the health care of our environment is vaccinated against Hepatitis B. The philosophy behind this concept is to protect oneself and others by vaccination. "To this we must add another fact that underscores the president of the Academy of Medical Sciences of Bilbao. "The policy approach of Public Health means that, thanks to the immunization schedule for children, young people entering the labor market are better protected than the older population."
Also, the time of updating the knowledge organized by the OVAL has reviewed the three most common types of vaccines in adults: influenza vaccine, tetanus vaccine and vaccines against hepatitis B. The head of vaccines and monitoring of management of Public Health of the Basque government, José María Arteagoitia has reviewed the current status of vaccine, and future prospects. This field is particularly important with the analysis of a virtual scene: how to act in the event of an influenza pandemic? The expert says that "has established a protocol on who to vaccinate first vaccination and what criteria should be followed."
In the field of tetanus vaccine, José Antonio Navarro-Alonso, a member of the European Commission on Prevention, revised criteria such as the risk of hipervacunación-economic carries a surcharge, the more discomfort and possible side-effects and lack of timing vaccine followed by the immigrant population. Following these reflections, Juan Goiri advocates the creation of a universal vaccination record, which reduces the margin of error. "
In any of the aforementioned types of vaccines, their administration is voluntary within the healthcare workplace. Unlike in the case of the vaccine for Hepatitis B. Luis Urbiztondo, section chief of infectious disease prevention for the general direction of Public Health of Catalonia, increased the possibility of reducing the number of doses required for a proper prophylaxis. Scientific research towards a vaccine for life ", a concept that, in the words of John Goiri," would significantly advance the health workforce of health professionals.
Some innovative practices workshops instruct medical residents about the physical examination of the locomotor system.
● Residents of Orthopedic Surgery and Traumatology have had the opportunity to train in the physical form of current, complete and practical.
● The conference took place within the Congress of the Spanish Society of osteoporotic fractures
Under the Second Congress of the Spanish Society of osteoporotic fracture (SEFRAOS), which is taking place these days in Madrid, there have been some innovative practices Exploration Workshop Physics Locomotive. The purpose of these meetings has been to offer a comprehensive and detailed knowledge of the specific exercises necessary to address the problems of locomotion. As commented by Dr. Antonio Rios, Orthopedic Surgery Service, Hospital Virgen del Mar de Almería, who has been a teacher "It is essential for proper diagnosis of any problem locomotor conducting a thorough physical examination it. This is a test of a very high reliability and great tradition, to which is added a series of radiological tests in order to obtain an accurate diagnosis. "
At the conference, sponsored by Bayer Schering Pharma, residents have orthopedic surgery and traumatology in Spain. Professor Francisco Gomar has been in charge of coordinating the practices taught by specialists who have carried out spot tests for structured exploration location: shoulder, knee, spine, hip, hand, ankle-foot.
According to Dr. Rios' One day as we have given are of great importance for the learning of medical residents as it is rare to receive such training. " It added that "practices, in the framework of a national congress, are quite novel in Spain. But in the American Congress is very common and make small workshops, several hours' duration, which focus on a specific part of the locomotor system, and study from beginning to end everything associated with it. I trust that these meetings will be repeated next year in the Congress of the SEFRAOS to become a tradition. "
Roundtable on thromboembolic disease
Bayer Schering Pharma also sponsors of this Congress in a Roundtable on thromboembolic disease tomorrow.
During the meeting, national experts will address various aspects of thromboprophylaxis: the role of primary care, the use of catheters, new drugs, etc..
Referring to the issue of new drugs for the treatment of thromboembolic disease, the European Commission in September 2008 authorized the sale of Xarelto ® (rivaroxaban), a new anticoagulant, and fixed-dose oral administration once daily for preventing the formation of venous blood clots in patients undergoing elective surgery for total hip replacement and knee. Bayer Schering Pharma will market Xarelto ® in Spain shortly, a drug that has been launched in over 15 countries worldwide.
The marketing authorization by the European Union (EU), was received after the evaluation of data from the RECORD clinical program that included three Phase III studies conducted with rivaroxaban, involving nearly 10,000 patients undergoing elective surgery of replacing hip or knee (RECORD1, RECORD2 and RECORD3). The results of this program demonstrate the superior efficacy of rivaroxaban compared with enoxaparin in both tests (RECORD1 and RECORD3) as compared to the long pattern of rivaroxaban (5 weeks) compared to the standard short (2 weeks) enoxaparin (RECORD2). In all three studies, rivaroxaban showed a comparable safety profile, including a low incidence of bleeding similar.
Xarelto ® provides the comfort of administration in the hospital and home, as it does not require monitoring or dose adjustment. As an oral treatment, unlike conventional heparins are administered by injection, and low risk of interactions with other drugs, it makes has all the characteristics the ideal anticoagulant. Rivaroxaban offers superior performance, without an increased risk of bleeding.
The extensive program of clinical trials of the drug make it an oral anticoagulant, direct Factor Xa inhibitor, the world's most studied so far. It is expected that over 60,000 patients are included in the clinical development program for rivaroxaban, which will investigate the product for the prevention and treatment of a wide range of diseases, both acute and chronic, related to blood clotting. For example the treatment of venous thromboembolism (VTE), prevention of stroke in patients with atrial fibrillation, the prevention of VTE in medical patients in hospitals and secondary prevention of acute coronary syndrome.
● The conference took place within the Congress of the Spanish Society of osteoporotic fractures
Under the Second Congress of the Spanish Society of osteoporotic fracture (SEFRAOS), which is taking place these days in Madrid, there have been some innovative practices Exploration Workshop Physics Locomotive. The purpose of these meetings has been to offer a comprehensive and detailed knowledge of the specific exercises necessary to address the problems of locomotion. As commented by Dr. Antonio Rios, Orthopedic Surgery Service, Hospital Virgen del Mar de Almería, who has been a teacher "It is essential for proper diagnosis of any problem locomotor conducting a thorough physical examination it. This is a test of a very high reliability and great tradition, to which is added a series of radiological tests in order to obtain an accurate diagnosis. "
At the conference, sponsored by Bayer Schering Pharma, residents have orthopedic surgery and traumatology in Spain. Professor Francisco Gomar has been in charge of coordinating the practices taught by specialists who have carried out spot tests for structured exploration location: shoulder, knee, spine, hip, hand, ankle-foot.
According to Dr. Rios' One day as we have given are of great importance for the learning of medical residents as it is rare to receive such training. " It added that "practices, in the framework of a national congress, are quite novel in Spain. But in the American Congress is very common and make small workshops, several hours' duration, which focus on a specific part of the locomotor system, and study from beginning to end everything associated with it. I trust that these meetings will be repeated next year in the Congress of the SEFRAOS to become a tradition. "
Roundtable on thromboembolic disease
Bayer Schering Pharma also sponsors of this Congress in a Roundtable on thromboembolic disease tomorrow.
During the meeting, national experts will address various aspects of thromboprophylaxis: the role of primary care, the use of catheters, new drugs, etc..
Referring to the issue of new drugs for the treatment of thromboembolic disease, the European Commission in September 2008 authorized the sale of Xarelto ® (rivaroxaban), a new anticoagulant, and fixed-dose oral administration once daily for preventing the formation of venous blood clots in patients undergoing elective surgery for total hip replacement and knee. Bayer Schering Pharma will market Xarelto ® in Spain shortly, a drug that has been launched in over 15 countries worldwide.
The marketing authorization by the European Union (EU), was received after the evaluation of data from the RECORD clinical program that included three Phase III studies conducted with rivaroxaban, involving nearly 10,000 patients undergoing elective surgery of replacing hip or knee (RECORD1, RECORD2 and RECORD3). The results of this program demonstrate the superior efficacy of rivaroxaban compared with enoxaparin in both tests (RECORD1 and RECORD3) as compared to the long pattern of rivaroxaban (5 weeks) compared to the standard short (2 weeks) enoxaparin (RECORD2). In all three studies, rivaroxaban showed a comparable safety profile, including a low incidence of bleeding similar.
Xarelto ® provides the comfort of administration in the hospital and home, as it does not require monitoring or dose adjustment. As an oral treatment, unlike conventional heparins are administered by injection, and low risk of interactions with other drugs, it makes has all the characteristics the ideal anticoagulant. Rivaroxaban offers superior performance, without an increased risk of bleeding.
The extensive program of clinical trials of the drug make it an oral anticoagulant, direct Factor Xa inhibitor, the world's most studied so far. It is expected that over 60,000 patients are included in the clinical development program for rivaroxaban, which will investigate the product for the prevention and treatment of a wide range of diseases, both acute and chronic, related to blood clotting. For example the treatment of venous thromboembolism (VTE), prevention of stroke in patients with atrial fibrillation, the prevention of VTE in medical patients in hospitals and secondary prevention of acute coronary syndrome.
The number of men affected by eating disorders.
Currently 8-10% of patients are men, especially youth sports
The Eating Disorders (ED) are increasingly affecting a wide profile of patients. Currently ranging from 10 years young, older people who have symptoms of the disease swept over much of his life and is at maturity when manifested more clearly.
Anorexia, bulimia and other eating disorders are not exclusive to women. Although the ratio is still there and 9 out of 10 affected women, plus the ever increasing number of men. According to the experience of the Eating Disorders Institute (ITA) the number of men affected by these diseases has increased in recent years, reaching around 8-10% of the total. These figures may vary depending on the clinical picture and age, but in the case of the men remained in anorexia and bulimia this data is even more frequent.
In regard to age, number of patients is higher with fewer years. Thus, between groups of prepubertal between 11-13 years reach a 25-30% incidence of the disease, and 15-20% decrease in 13-14 years.
Eating disorders are also more frequently in certain groups who practice sports of effort such as gymnasts, jockeys, dancers, or skaters.
Changing profile of patients with TCA
In the 10 years history of ITA, 101 boys have passed constituting 5% of the total admitted to the hospital. Has been basically since 2005 that has begun to raise the incidence of these disorders in males and in the last year has led to double the number of patients treated at the Institute.
Eating Disorders in the male
In practice, the symptoms of eating disorders in males is very similar to that of women, but you can highlight the following aspects:
• Men with anorexia are more obsessed than women, with a tendency to intellectualise, perfectionism and rigidity.
• In men allegedly stealing more and more compulsive emotional stress.
• It is more often a history of overweight, both in patient and family, more somatic complaints, more and more psychiatric comorbidity disorders among family members of men
• An important aspect is related to hyperactivity. Has established the presence of hyper-inflated until exhaustion as a mechanism of weight control much more common in men.
• The environment of the ED is related to the cultures, the unbridled passion for fitness, concern for the body to develop muscles and shape the figure.
• love cooking for others, love to make huge and unnecessary purchases of food, collecting cookbooks, the composition of food, calories, forcing others to eat even without wishing to do so, because many hours in the kitchen, etc.
• It has linked the ED in men with sexual identity. Greater proportion of homosexuals. They were more dissatisfied with their shape and weight than heterosexuals and more concerned with the physical layout and appearance.
• "sexual alexithymia: difficulty to feel and express emotions or communicate their feelings on everything that relates to the sexual area.
• Regarding the precipitating stress is at a higher intensity and more.
About ITA
The Eating Disorders Institute (ITA) is a health care network founded in 1998 for treatment, training and investigation of disturbances in eating behavior. This is the main institution at the state level in private care for Eating Disorders (ED). The institution understands that the care of such disorders must encompass not only preventing disease and restoring health, but also the rehabilitation and reintegration into their environment.
ITA offers a variety of healthcare resources to achieve its objectives: inpatient facilities, day hospitals, outpatient and medical floors. This is the first center in Spain in terms of number of beds and patients.
The Eating Disorders (ED) are increasingly affecting a wide profile of patients. Currently ranging from 10 years young, older people who have symptoms of the disease swept over much of his life and is at maturity when manifested more clearly.
Anorexia, bulimia and other eating disorders are not exclusive to women. Although the ratio is still there and 9 out of 10 affected women, plus the ever increasing number of men. According to the experience of the Eating Disorders Institute (ITA) the number of men affected by these diseases has increased in recent years, reaching around 8-10% of the total. These figures may vary depending on the clinical picture and age, but in the case of the men remained in anorexia and bulimia this data is even more frequent.
In regard to age, number of patients is higher with fewer years. Thus, between groups of prepubertal between 11-13 years reach a 25-30% incidence of the disease, and 15-20% decrease in 13-14 years.
Eating disorders are also more frequently in certain groups who practice sports of effort such as gymnasts, jockeys, dancers, or skaters.
Changing profile of patients with TCA
In the 10 years history of ITA, 101 boys have passed constituting 5% of the total admitted to the hospital. Has been basically since 2005 that has begun to raise the incidence of these disorders in males and in the last year has led to double the number of patients treated at the Institute.
Eating Disorders in the male
In practice, the symptoms of eating disorders in males is very similar to that of women, but you can highlight the following aspects:
• Men with anorexia are more obsessed than women, with a tendency to intellectualise, perfectionism and rigidity.
• In men allegedly stealing more and more compulsive emotional stress.
• It is more often a history of overweight, both in patient and family, more somatic complaints, more and more psychiatric comorbidity disorders among family members of men
• An important aspect is related to hyperactivity. Has established the presence of hyper-inflated until exhaustion as a mechanism of weight control much more common in men.
• The environment of the ED is related to the cultures, the unbridled passion for fitness, concern for the body to develop muscles and shape the figure.
• love cooking for others, love to make huge and unnecessary purchases of food, collecting cookbooks, the composition of food, calories, forcing others to eat even without wishing to do so, because many hours in the kitchen, etc.
• It has linked the ED in men with sexual identity. Greater proportion of homosexuals. They were more dissatisfied with their shape and weight than heterosexuals and more concerned with the physical layout and appearance.
• "sexual alexithymia: difficulty to feel and express emotions or communicate their feelings on everything that relates to the sexual area.
• Regarding the precipitating stress is at a higher intensity and more.
About ITA
The Eating Disorders Institute (ITA) is a health care network founded in 1998 for treatment, training and investigation of disturbances in eating behavior. This is the main institution at the state level in private care for Eating Disorders (ED). The institution understands that the care of such disorders must encompass not only preventing disease and restoring health, but also the rehabilitation and reintegration into their environment.
ITA offers a variety of healthcare resources to achieve its objectives: inpatient facilities, day hospitals, outpatient and medical floors. This is the first center in Spain in terms of number of beds and patients.
Subscribe to:
Posts (Atom)
